Home › Bladder Cancer › Massachusetts › Worcester
Bladder Cancer clinical trials in Worcester, MA
4 studies for Bladder Cancer are looking for participants at sites in and around Worcester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RecruitingPhase 2
- UMass Memorial Medical Center - University Campus, Worcester
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- University of Massachusetts Medical School, Worcester
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecruitingPhase 2
- UMass Memorial Medical Center, Worcester
- University of Massachusetts Chan Medical School, Worcester
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Worcester
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY34 studies
- Houston, TX31 studies
- Nashville, TN31 studies
- Boston, MA27 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Edison, NJ22 studies
- Philadelphia, PA21 studies
- Seattle, WA21 studies
Other studies in Worcester
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Cancer (all types)7 studies
- Breast Cancer6 studies
- Major Depressive Disorder5 studies
- Acute Myeloid Leukemia5 studies
- Ovarian Cancer5 studies
- Schizophrenia5 studies
- Depression5 studies
- Metastatic Cancer5 studies
- Prostate Cancer5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.